Healthcare provider profile · identity verified

Vigneswaran Kandiah, MD

Internal Medicine · CLINTON, NY · NPI 1124017249

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	506	124
Rosuvastatin Calcium	Rosuvastatin Calcium	443	141
Losartan Potassium	Losartan Potassium	421	116
Levothyroxine Sodium	Levothyroxine Sodium	372	79
Omeprazole	Omeprazole	342	80
Metoprolol Succinate	Metoprolol Succinate	338	97
Amlodipine Besylate	Amlodipine Besylate	321	88
Tamsulosin Hcl	Tamsulosin Hcl	293	65
Fluticasone Propionate	Fluticasone Propionate	287	124
Pantoprazole Sodium	Pantoprazole Sodium	271	78
Metformin Hcl	Metformin Hcl	232	51
Eliquis	Apixaban	217	41
Albuterol Sulfate Hfa	Albuterol Sulfate	201	90
Hydrochlorothiazide	Hydrochlorothiazide	189	58
Escitalopram Oxalate	Escitalopram Oxalate	180	54
Gabapentin	Gabapentin	171	54
Alprazolam	Alprazolam	157	29
Famotidine	Famotidine	157	40
Glimepiride	Glimepiride	154	37
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	134	42
Potassium Chloride	Potassium Chloride	133	36
Allopurinol	Allopurinol	121	34
Spironolactone	Spironolactone	121	30
Montelukast Sodium	Montelukast Sodium	120	26
Duloxetine Hcl	Duloxetine Hcl	118	34
Lisinopril	Lisinopril	113	33
Ezetimibe	Ezetimibe	111	26
Bisoprolol Fumarate	Bisoprolol Fumarate	102	26
Hydralazine Hcl	Hydralazine Hcl	99	26
Metoprolol Tartrate	Metoprolol Tartrate	98	30
Mirtazapine	Mirtazapine	98	22
Furosemide	Furosemide	94	28
Fenofibrate	Fenofibrate	87	23
Prednisone	Prednisone	86	62
Jardiance	Empagliflozin	83	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	78	19
Simvastatin	Simvastatin	76	23
Alendronate Sodium	Alendronate Sodium	73	14
Pravastatin Sodium	Pravastatin Sodium	73	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	67	17
Chlorthalidone	Chlorthalidone	66	22
Glipizide Er	Glipizide	66	20
Sertraline Hcl	Sertraline Hcl	65	18
Meloxicam	Meloxicam	63	27
Linzess	Linaclotide	60	suppressed
Lactulose	Lactulose	59	12
Torsemide	Torsemide	59	16
Zolpidem Tartrate	Zolpidem Tartrate	59	18
Levetiracetam	Levetiracetam	56	suppressed
Donepezil Hcl	Donepezil Hcl	54	13
Ipratropium Bromide	Ipratropium Bromide	54	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	52	35
Divalproex Sodium	Divalproex Sodium	52	suppressed
Glipizide	Glipizide	49	12
Tramadol Hcl	Tramadol Hcl	49	12
Lovastatin	Lovastatin	47	13
Sucralfate	Sucralfate	46	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	45	suppressed
Azithromycin	Azithromycin	44	41
Ozempic	Semaglutide	44	suppressed
Xarelto	Rivaroxaban	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	42	15
Breo Ellipta	Fluticasone/Vilanterol	41	12
Folic Acid	Folic Acid	40	13
Bupropion Xl	Bupropion Hcl	39	14
Finasteride	Finasteride	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	39	12
Buspirone Hcl	Buspirone Hcl	38	14
Januvia	Sitagliptin Phosphate	37	suppressed
Ramipril	Ramipril	37	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	37	13
Synthroid	Levothyroxine Sodium	33	11
Carvedilol	Carvedilol	32	12
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	11
Labetalol Hcl	Labetalol Hcl	32	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Valsartan	Valsartan	30	suppressed
Cefuroxime	Cefuroxime Axetil	29	25
Ciclopirox	Ciclopirox	29	13
Creon	Lipase/Protease/Amylase	29	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	19
Glycopyrrolate	Glycopyrrolate	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	13
Lacosamide	Lacosamide	28	suppressed
Lamotrigine	Lamotrigine	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	28	suppressed
Olanzapine	Olanzapine	28	suppressed
Topiramate	Topiramate	28	suppressed
Trazodone Hcl	Trazodone Hcl	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	16
Clonazepam	Clonazepam	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	17
Memantine Hcl	Memantine Hcl	26	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	25	suppressed
Lorazepam	Lorazepam	25	11
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Klor-Con M10	Potassium Chloride	24	suppressed
Nebivolol Hcl	Nebivolol Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Atenolol	Atenolol	23	suppressed
Clotrimazole	Clotrimazole	23	11
Digoxin	Digoxin	23	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Nifedipine Er	Nifedipine	23	suppressed
Risperidone	Risperidone	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Icosapent Ethyl	Icosapent Ethyl	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Bumetanide	Bumetanide	21	suppressed
Cephalexin	Cephalexin	21	18
Clobetasol Propionate	Clobetasol Propionate	21	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Dutasteride	Dutasteride	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	19
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Irbesartan	Irbesartan	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Nystatin	Nystatin	17	suppressed
Repatha Sureclick	Evolocumab	17	suppressed
Hydrocortisone	Hydrocortisone	16	12
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	13	suppressed
Captopril	Captopril	13	suppressed
Diazepam	Diazepam	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Lidocaine	Lidocaine	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Baclofen	Baclofen	11	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	11	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	11	suppressed
Hydrocortisone Valerate	Hydrocortisone Valerate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Temazepam	Temazepam	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error